Complement Component 3 expressed by the endometrial ectopic tissue is involved in the endometriotic lesion formation through mast cell activation

The pathophysiology of endometriosis (EM) is an excellent example of immune dysfunction, reminiscent of tumor microenvironment as well. Here, we report that an interplay between C3 and mast cells (MCs) is involved in the pathogenesis of ectopic EM. C3 is at the epicenter of the regulatory feed forward loop, amplifying the inflammatory microenvironment, in which the MCs are protagonists. Thus, C3 can be considered a marker of EM and its local synthesis can promote the engraftment of the endometriotic cysts. We generated a murine model of EM via injection of minced uterine tissue from a donor mouse, into the peritoneum of the recipient mice. The wild type mice showed greater amount of cyst formation in the peritoneum compared to C3 knock-out mice. This study offers an opportunity for novel therapeutic intervention in EM, a difficult to treat gynecological condition. Summary C3 produced by the endometriotic tissue is involved in the lesion development through mast cell activation

[1]  B. Nilsson,et al.  Assessment of the Role of C3(H2O) in the Alternative Pathway , 2020, Frontiers in Immunology.

[2]  A. Witek,et al.  The role of complement components C1q, MBL and C1 inhibitor in pathogenesis of endometriosis , 2018, Archives of Gynecology and Obstetrics.

[3]  Anne Mari Roost,et al.  High-throughput mRNA sequencing of stromal cells from endometriomas and endometrium. , 2017, Reproduction.

[4]  J. Donnez,et al.  Targeting mast cells: a new way to treat endometriosis , 2017, Expert opinion on therapeutic targets.

[5]  S. Young,et al.  Immune-inflammation gene signatures in endometriosis patients. , 2016, Fertility and sterility.

[6]  W. Nelen,et al.  Selection of Key Recommendations for the 1 Management of Women with Endometriosis by 2 an International Panel of Patients and 3 Professionals , 2016 .

[7]  L. Giudice,et al.  Update on Biomarkers for the Detection of Endometriosis , 2015, BioMed research international.

[8]  G. Zauli,et al.  The Combination of N-Acetyl Cysteine, Alpha-Lipoic Acid, and Bromelain Shows High Anti-Inflammatory Properties in Novel In Vivo and In Vitro Models of Endometriosis , 2015, Mediators of inflammation.

[9]  Alfonso Baldi,et al.  Serum Biomarker for Diagnosis of Endometriosis , 2014, Journal of cellular physiology.

[10]  G. Tseng,et al.  Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer , 2014, Clinical Cancer Research.

[11]  G. Remuzzi,et al.  Overview of Complement Activation and Regulation , 2013, Seminars in nephrology.

[12]  Annalisa Capobianco,et al.  Endometriosis, a disease of the macrophage , 2013, Front. Immun..

[13]  Takashi Takahashi,et al.  The ferroimmunomodulatory role of ectopic endometriotic stromal cells in ovarian endometriosis. , 2012, Fertility and sterility.

[14]  P. Viganò,et al.  The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation. , 2012, Human reproduction.

[15]  T. Zollner,et al.  Mast cells in endometriosis: guilty or innocent bystanders? , 2012, Expert opinion on therapeutic targets.

[16]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[17]  J. Fourquet,et al.  Single-nucleotide polymorphisms in the lysyl oxidase-like protein 4 and complement component 3 genes are associated with increased risk for endometriosis and endometriosis-associated infertility. , 2011, Fertility and sterility.

[18]  C. Becker,et al.  Peripheral biomarkers of endometriosis: a systematic review. , 2010, Human reproduction update.

[19]  Xiaomei Zhang,et al.  Expression of immunomodulatory genes, their protein products and specific ligands/receptors during the window of implantation in the human endometrium. , 2008, Molecular human reproduction.

[20]  J. Sikora,et al.  Levels of complement components iC3b, C3c, C4, and SC5b-9 in peritoneal fluid and serum of infertile women with endometriosis. , 2007, Fertility and sterility.

[21]  J. Waitumbi,et al.  Hematin Promotes Complement Alternative Pathway-Mediated Deposition of C3 Activation Fragments on Human Erythrocytes: Potential Implications for the Pathogenesis of Anemia in Malaria1 , 2007, The Journal of Immunology.

[22]  John D Lambris,et al.  The role of complement in inflammatory diseases from behind the scenes into the spotlight. , 2007, The American journal of pathology.

[23]  Idhaliz Flores,et al.  Molecular profiling of experimental endometriosis identified gene expression patterns in common with human disease. , 2007, Fertility and sterility.

[24]  B. Nilsson,et al.  Complement and coagulation: strangers or partners in crime? , 2007, Trends in immunology.

[25]  A. Fazleabas,et al.  Identification of novel genes regulated by chorionic gonadotropin in baboon endometrium during the window of implantation. , 2007, Endocrinology.

[26]  C. Chapron,et al.  Pain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis. , 2006, Fertility and sterility.

[27]  M. Sugamata,et al.  Increase of Activated Mast Cells in Human Endometriosis , 2005, American journal of reproductive immunology.

[28]  G. Sant,et al.  Increased Numbers of Activated Mast Cells in Endometriosis Lesions Positive for Corticotropin‐Releasing Hormone and Urocortin , 2004, American journal of reproductive immunology.

[29]  Mitsuaki Suzuki,et al.  Localization of Mast Cells in Endometrial Cysts , 2004, American journal of reproductive immunology.

[30]  Mitsuaki Suzuki,et al.  Role of immunoreactions and mast cells in pathogenesis of human endometriosis-morphologic study and gene expression analysis- , 2003, Human Cell.

[31]  T. Falcone,et al.  Peritoneal fluid environment in endometriosis. Clinicopathological implications. , 2003, Minerva ginecologica.

[32]  A. Agarwal,et al.  Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. , 2002, Human reproduction.

[33]  M. Walport,et al.  Complement. Second of two parts. , 2001, The New England journal of medicine.

[34]  M. Walport Complement. First of two parts. , 2001, The New England journal of medicine.

[35]  L. Twiggs,et al.  Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue. , 2000, Gynecologic oncology.

[36]  P. Viganò,et al.  Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis. , 1999, Human reproduction.

[37]  A. Yajima,et al.  Increased Mast Cell Density in Peritoneal Endometriosis Compared with Eutopic Endometrium with Endometriosis , 1998, American journal of reproductive immunology.

[38]  Wiklund Ra,et al.  First of two parts , 1997 .

[39]  M. Canis,et al.  Revised American Society for Reproductive Medicine classification of endometriosis: 1996. , 1997, Fertility and sterility.

[40]  K. Isaacson,et al.  Localization of the expression of complement component 3 in the human endometrium by in situ hybridization. , 1996, The Journal of clinical endocrinology and metabolism.

[41]  P. Butko,et al.  Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Campana,et al.  Investigations on the cell type responsible for the endometrial secretion of complement component 3 (C3). , 1994, Human reproduction.

[43]  S. Kennedy Endometriosis , 1992, The Lancet.

[44]  C. Lyttle,et al.  The effect of estradiol on the production and secretion of complement component 3 by the rat uterus and surgically induced endometriotic tissue. , 1991, Fertility and sterility.

[45]  C. Lyttle,et al.  Production and secretion of complement component 3 by endometriotic tissue. , 1989, The Journal of clinical endocrinology and metabolism.

[46]  J. Collins,et al.  Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery. , 1988, Fertility and sterility.

[47]  P. Arquembourg,et al.  Endometriosis: can it produce an autoimmune response resulting in infertility? , 1980, Clinical obstetrics and gynecology.

[48]  S. Mott Supervised Study , 1917 .

[49]  R. Harrison The properdin pathway: an “alternative activation pathway” or a “critical amplification loop” for C3 and C5 activation? , 2017, Seminars in Immunopathology.

[50]  C. Gil,et al.  The intricate role of mast cell proteases and the annexin A1-FPR1 system in abdominal wall endometriosis , 2014, Journal of Molecular Histology.

[51]  R. M. Ackay,et al.  First of Two Parts , 2013 .

[52]  小林 浩治 The ferroimmunomodulatory role of ectopic endometriotic stromal cells in ovarian endometriosis , 2012 .

[53]  A. Mackay-Sim,et al.  Validation of the comparative quantification method of real-time PCR analysis and a cautionary tale of housekeeping gene selection , 2008 .

[54]  Wolfgang Amadens The Second of Two Parts , 2003 .

[55]  T. Falcone,et al.  Peritoneal fluid environment in endometriosis , 2003 .

[56]  R. Milano Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis , 1999 .

[57]  I. Damjanov,et al.  Immunoproteins in the endometrium: clinical correlates of the presence of complement fractions C3 and C4. , 1987, American journal of obstetrics and gynecology.